Impact of loss to follow-up on survival estimation for cystic fibrosis

被引:3
作者
Ostrenga, Joshua S. [1 ,3 ]
Brown, A. Whitney [1 ]
Todd, Jonathan, V [1 ]
Elbert, Alexander [1 ]
Fink, Aliza K. [2 ]
Faro, Albert [1 ]
Marshall, Bruce C. [1 ]
Cromwell, Elizabeth A. [1 ]
机构
[1] Cyst Fibrosis Fdn, Clin Affairs, Bethesda, MD USA
[2] Natl Org Rare Disorders, Res Programs, Washington, DC USA
[3] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA
关键词
Cystic fibrosis; Registry data; Survival analysis; Loss to follow-up; DIAGNOSIS; GUIDELINES; ADULTS;
D O I
10.1016/j.annepidem.2023.07.008
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Deaths among those lost to follow-up (LTFU) in the Cystic Fibrosis Foundation Patient Registry (CFFPR) are critically important to the epidemiology of cystic fibrosis (CF). Unreported deaths could impact estimates of survival if LTFU is associated with disease trajectory.Methods: We characterized the LTFU population (1986-2017) from the CFFPR and identified deaths via linkage with the National Death Index (NDI). Median predicted survival age and conditional survival were estimated with and without additional deaths and person-time from the NDI.Results: Of the 10,582 individuals LTFU in the CFFPR, 2,460 (23.2%) matched to an NDI death record. Individuals who died after LTFU with a CF diagnosis were 43% female, 91% White/non-Hispanic, 59% had advanced CF lung disease based on last CFFPR recorded forced expiratory volume in one second (FEV1) %predicted < 40 and 18% were post-lung transplant. Median predicted survival age during the most recent period available, 2013-2017, increased from 44.3 years (95% CI: 43.2, 45.7) to 45.8 years (95% CI 44.5, 47.1) with the inclusion of NDI data.Conclusions: Inclusion of deaths and additional person-time among those LTFU changed the point estimate of median predicted survival for most time periods and increased the point estimate from 2009 onwards.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / +
页数:11
相关论文
共 50 条
  • [1] Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis
    Lavie, Moran
    Manovitz, Tzipora
    Vilozni, Daphna
    Levy-Mendelovich, Sarina
    Sarouk, Ifat
    Weintraubv, Ilana
    Shoseyov, David
    Cohen-Cymberknoh, Malena
    Rivlin, Joseph
    Efrati, Ori
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (01) : 318 - 325
  • [2] Follow-up protocol of patients with cystic fibrosis diagnosed by newborn screening
    Gartner, Silvia
    Mondejar-Lopez, Pedro
    Asensio de la Cruz, Oscar
    Jose Alonso, Maria
    Alvarez, Marina
    Andres Martin, Anselmo
    Barrio Gomez de Aguero, Maria Isabel
    Cabero Perez, Maria Jesus
    Caro Aguilera, Pilar
    Cols Roig, Maria
    Cortell Aznar-Perez, Isidoro
    Costa Colomer, Jordi
    Delgado Pecellin, Isabel
    Escribano Montaner, Amparo
    Figuerola Mulet, Joan
    Garcia Hernandez, Gloria
    Guayarte, Pilar
    Gil Ortega, David
    Gomez Pastrana, David
    Lamas Ferreiro, Adelaida
    Marin Soria, Jose Luis
    Martin de Vicente, Carlos
    Navarro Merino, Martin
    Oliva Hernandez, Concepcion
    Perez Frias, Javier
    Perez Ruiz, Estela
    Rovira Amigo, Sandra
    Salcedo Posadas, Antonio
    Sanchez-Solis, Manuel
    Sirvent Gomez, Josep
    Vazquez Cordero, Carlos
    Villa Asensi, Jose Ramon
    ANALES DE PEDIATRIA, 2019, 90 (04):
  • [3] Impact of practice recommendations on patient follow-up and cystic fibrosis centres' activity in France
    Decullier, Evelyne
    Touzet, Sandrine
    Bourdy, Stephanie
    Termoz, Anne
    Bellon, Gabriel
    Pin, Isabelle
    Cracowski, Claire
    Colin, Cyrille
    Durieu, Isabelle
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (01) : 70 - 75
  • [4] LOSS TO FOLLOW-UP WEIGHTED ESTIMATION METHOD FOR SURVIVAL ANALYSIS
    Krishna, K. M. Jagathnath
    Hari, Akash
    Traison, T.
    George, Preethi Sara
    Mathew, Aleyamma
    ADVANCES AND APPLICATIONS IN STATISTICS, 2023, 85 : 55 - 78
  • [5] Gynecological management and follow-up in women with cystic fibrosis
    Rousset-Jablonski, C.
    Reynaud, Q.
    Nove-Josserand, R.
    Durupt, S.
    Durieu, I.
    REVUE DES MALADIES RESPIRATOIRES, 2018, 35 (06) : 592 - 603
  • [6] Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up
    Fila, Libor
    Bartakova, Lucie Valentova
    Grandcourtova, Alzbeta
    Marel, Miloslav
    Drnek, Radovan
    Bilkova, Alena
    Macek, Milan, Jr.
    Drevinek, Pavel
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (02): : 276 - 279
  • [7] LONGITUDINAL TRANSIENT ELASTOGRAPHY MEASUREMENTS USED IN FOLLOW-UP FOR PATIENTS WITH CYSTIC FIBROSIS
    Van Biervliet, Stephanie
    Verdievel, Hugo
    Vande Velde, Saskia
    De Bruyne, Ruth
    De Looze, Danny
    Verhelst, Xavier
    Geerts, Anja
    Robberecht, Eddy
    Van Vlierberghe, Hans
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2016, 42 (04) : 848 - 854
  • [8] Evaluation of diagnosis and follow-up in screened children with cystic fibrosis in Normandy.
    Brouard, J
    Lecoq, I
    Viel, JF
    Guillot, M
    Laurans, M
    Laroche, D
    Travert, G
    Duhamel, JF
    ARCHIVES DE PEDIATRIE, 2001, 8 : 603S - 609S
  • [9] Improving cystic fibrosis survival as a result of management in a specialized Center with 10-year follow-up
    Lentini N, Eduardo
    Lopez-Millan, Adriana
    Lores L, Ana Maria
    Pesciullesi B, Maria Rosa
    Ituarte R, Leonor Maria
    Viera C, Teresa Beatriz
    REVISTA CHILENA DE PEDIATRIA-CHILE, 2014, 85 (03): : 281 - 287
  • [10] Clinical Outcomes and Prognostic Factors in a Cohort of Adults With Cystic Fibrosis: A 7-Year Follow-Up Study
    Flores, Josani Silva
    Eidt Rovedder, Paula Maria
    Ziegler, Bruna
    Furlan Pinotti, Antonio Fernando
    Menna Barreto, Sergio Saldanha
    Roth Dalcin, Paulo de Tarso
    RESPIRATORY CARE, 2016, 61 (02) : 192 - 199